Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of altSonflex1.2.3 Shigella vaccine in infants
PACTR202402550507294Phase 2Not yet recruiting
- Sponsor
- GSK
- Start
- Aug 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial in shigellosis (4 arms), sponsored by GSK. Planned start Aug 2024; status: not yet recruiting.
02
Conditions
shigellosis
Beyond the preview
Go deeper on PACTR202402550507294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402550507294.